Jazz Pharmaceuticals plc Quarterly Goodwill in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Jazz Pharmaceuticals plc quarterly Goodwill history and growth rate from Q4 2010 to Q3 2024.
  • Jazz Pharmaceuticals plc Goodwill for the quarter ending September 30, 2024 was $1.8B, a 5.82% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.8B +$99.3M +5.82% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.74B -$6.74M -0.39% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.74B +$16.1M +0.93% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.75B +$60.5M +3.57% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.71B +$113M +7.08% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.74B +$55M +3.26% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.72B -$59M -3.31% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.69B -$135M -7.38% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $1.59B -$257M -13.9% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.69B -$200M -10.6% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.78B +$844M +89.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.83B +$869M +90.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $1.85B +$912M +97.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.89B +$970M +106% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $938M +$29.2M +3.21% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $958M +$38.3M +4.16% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $937M +$30.4M +3.35% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $918M -$6.97M -0.75% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $909M -$10.7M -1.17% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $920M -$7.61M -0.82% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $907M -$25.7M -2.76% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $925M -$11.5M -1.23% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $920M -$40.5M -4.22% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $928M -$19.9M -2.1% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $932M -$9.01M -0.96% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $936M +$10.2M +1.1% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $961M +$61.2M +6.81% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $948M +$53.7M +6.01% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $941M +$13.4M +1.45% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $926M +$264M +40% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $899M +$228M +34% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $894M +$237M +36% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $928M +$259M +38.7% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $662M -$2.17M -0.33% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $671M +$16.5M +2.52% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $657M -$45.6M -6.49% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $669M -$55.4M -7.64% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $664M -$96.3M -12.7% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $654M -$109M -14.3% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $703M +$252M +56% Dec 31, 2014 10-K 2016-02-23
Q3 2014 $724M +$278M +62.1% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $760M +$321M +73.2% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $764M +$327M +75% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $450M +$7.86M +1.78% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $447M +$9.17M +2.1% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $439M -$7.22M -1.62% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $436M +$197M +82% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $443M +$404M +1058% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $438M +$399M +1045% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $446M +$408M +1068% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $240M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $38.2M $0 0% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $38.2M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $38.2M Jun 30, 2011 10-Q 2011-08-03
Q4 2010 $38.2M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.